scholarly journals Physician uncertainty aversion impacts medical decision making for older patients with acute myeloid leukemia: results of a national survey

Haematologica ◽  
2018 ◽  
Vol 103 (12) ◽  
pp. 2040-2048 ◽  
Author(s):  
Pierre Bories ◽  
Sébastien Lamy ◽  
Célestine Simand ◽  
Sarah Bertoli ◽  
Cyrille Delpierre ◽  
...  
Blood ◽  
2020 ◽  
Vol 136 (Supplement 1) ◽  
pp. 19-19
Author(s):  
Xia Wu ◽  
Yi-Nan Jiang ◽  
Yue-Lun Zhang ◽  
Jia Chen ◽  
Yue-ying Mao ◽  
...  

Introduction: The treatment strategy for elderly patients with acute myeloid leukemia (AML) is individualized due to the heterogeneity of the disease biology and the paucity of strong evidence in clinical practice. In general, regimens for elderly AML patients can be divided into standard intensive induction, low-intensity therapy, and best supportive care. Such medical decision-making regarding elderly patients with AML might be affected by physicians' occupational and non-occupational factors. Methods: We performed a national vignette-based survey of hematologists in China, to explore the impact of hematologists' personality and behavioral traits on medical decision-making for elderly AML patients. The medical decision-making for elderly AML patients was evaluated using 6 clinical vignettes. Hematologists' attitudes toward risk and uncertainty, personality traits, and decision-making styles were assessed using binary lottery choices and well-recognized self-report inventories. Results: Of the 820 eligible hematologists contacted, a total of 529 completed the survey; the response rate was 64.5%. In total, 354 (67%) were women. The mean age of the participants was 41.0 ± 7.4 years (range, 27-64 years). Senior hematologists accounted for 60% (n = 318) of the participants, including associate chief physicians (185, 35%) and chief physicians (133, 25%). The rest attending physicians, which are considered as junior hematologists, accounted for 40% of the participants (n = 211). The resulting binary regression model in predicting the therapy intensity preference of medical decision-making for elderly AML patients contained the following factors: hematologists' professional title group (OR = 0.012, 95% CI, 0.001 to 0.136, P < 0.001), conscientiousness (OR = 0.336, 95% CI, 0.121 to 0.932, P = 0.036), extraversion (OR = 0.403, 95% CI, 0.166 to 0.974, P = 0.044), conscientiousness by title group (OR = 2.009, 95% CI, 1.100 to 3.667, P = 0.023), and extraversion by title group (OR = 1.627, 95% CI, 0.965 to 2.743, P = 0.068). Using interaction analyses, we found that junior hematologists with a higher level of extraversion (mean difference = 0.27; 95% CI, 0.07 to 0.45; P = 0.009) or conscientiousness (mean difference = 0.19; 95% CI, 0.01 to 0.36; P = 0.028) tended to prescribe more intensive therapy. Meanwhile, no significant correlations between physicians' nonoccupational characteristics and medical decision-making for elderly AML patients were observed in senior hematologists. Conclusions: Our study suggests that hematologists' personalities contribute to medical decision-making for elderly AML patients, depending on the hematologists' professional titles. Among attending physicians, those with a higher level of extraversion or conscientiousness tended to prescribe more intensive therapy. Meanwhile, in chief and associate chief physicians, there was no significant correlation observed between hematologists' personality traits and medical decision-making for elderly AML patients. Disclosures No relevant conflicts of interest to declare.


Hematology ◽  
2020 ◽  
Vol 2020 (1) ◽  
pp. 51-56
Author(s):  
Alison R. Walker

Abstract Until recently, treatment options for patients with acute myeloid leukemia (AML) were limited to cytotoxic chemotherapeutic agents that possessed little specificity for the cytogenetic and molecular mutations known to risk stratify patients with this disease. With the approval of multiple new therapies, not only have the agents that we treat patients with changed, but the way we talk about these options, decide on, and manage therapy has also been transformed. Given these complexities, it is important that we help patients make an informed decision by weighing the risk of relapse with patient wishes and desired quality of life. Shared decision making (SDM) is an approach to medical decision making for those situations in which most clinicians would agree that there is more than 1 correct choice for a patient. Here we review the principles of SDM and provide an overview of the 3-talk model and how it may be incorporated into the care of patients with AML.


Leukemia ◽  
2016 ◽  
Vol 30 (7) ◽  
pp. 1485-1492 ◽  
Author(s):  
C-H Tsai ◽  
H-A Hou ◽  
J-L Tang ◽  
C-Y Liu ◽  
C-C Lin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document